Name
Arcus Biosciences
Company Description
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing first- or best-in-class medicines against well-characterized biological targets and pathways that have the potential to help people with cancer live longer. The company has advanced multiple investigational medicines into registrational clinical trials including casdatifan, a HIF-2a inhibitor for clear cell renal cell carcinoma, and quemliclustat, a small-molecule CD73 inhibitor for pancreatic cancer. For more information about Arcus Biosciences, please visit www.arcusbio.com.
Website
Product Categories (5)
Gastrointestinal (Colorectal) Cancer, Genitourinary Cancer, Clinical Trials, Drug Development, Immunotherapy
Address
Hayward, CA
United States
United States